
Emstal 1mg/ml Suspension
Marketer
Mars Therapeutics & Chemicals Ltd
Salt Composition
Domperidone (1mg/ml)
Overview Emstal 1mg/ml Suspension
PediaGast 1mg/ml oral suspension aids in managing indigestion, gastroesophageal reflux, nausea, and vomiting in pediatric patients. It accelerates gastric emptying and intestinal transit, alleviating symptoms such as bloating, satiety, and stomach upset. Administer PediaGast 1mg/ml suspension approximately 30 minutes prior to each meal for optimal absorption. Post-prandial administration remains effective, though absorption might be slightly reduced. Infants may require a four-times-daily regimen as directed by their physician, spaced at least four hours apart, ideally just before feeding. Dosage is individualized based on the child's age, weight, and condition. Never extend treatment beyond the prescribed duration without consulting your pediatrician. If vomiting occurs within 30 minutes of ingestion, repeat the dose once the child is calm; however, avoid doubling the dose if it's near the next scheduled time. Minor, transient side effects like dry mouth, headache, somnolence, abdominal cramps, and diarrhea are possible; these typically resolve with continued use. Persistent or concerning side effects warrant immediate medical attention. Inform your child's physician of any prior allergies, cardiac issues, hematological disorders, congenital anomalies, respiratory compromise, pulmonary abnormalities, gastrointestinal problems, dermatological conditions, hepatic impairment, or renal dysfunction. A complete medical history is crucial for accurate dosage adjustments and effective treatment planning.
Uses of Emstal 1mg/ml Suspension
Managing gastroesophageal reflux disease (GERD), indigestion, nausea, and vomiting.
Major Benefits of Emstal 1mg/ml Suspension:
Administer this medication orally, following your physician's prescribed dosage and schedule. Consult the product label for usage instructions prior to consumption. Utilize a measuring device for accurate dispensing. Ensure thorough shaking before each dose. Emstal 1mg/ml Suspension should be ingested on an empty stomach.
Common Side effects of Emstal 1mg/ml Suspension:
- Dryness in mouth
- Headache
- Drowsiness
- Stomach cramp
- Diarrhea
How to use Emstal 1mg/ml Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Consult the product label for complete instructions prior to consumption. Use a measuring device to accurately dispense the oral dose. Ensure thorough shaking before each use. Emstal 1mg/ml Suspension should be ingested on an empty stomach.
How Emstal 1mg/ml Suspension works:
Emstal 1mg/ml oral suspension is a motility stimulant. Its mechanism involves central action in the brain's emetic center, suppressing nausea and vomiting. Peripherally, it enhances gastrointestinal motility, facilitating improved gastric emptying and intestinal transit.
SAFETY ADVICE
KidneyCAUTION
For individuals with severe kidney impairment, administration of Emstal 1mg/ml Suspension requires careful consideration. Dosage modification of Emstal 1mg/ml Suspension might be necessary. Physician consultation is advised. Especially during prolonged treatment, routine assessment of kidney function is recommended.
LiverCAUTION
Patients with hepatic impairment should use Emstal 1mg/ml Suspension judiciously, potentially requiring dosage modification. Physician consultation is advised. Emstal 1mg/ml Suspension is contraindicated in children exhibiting severe liver dysfunction; pediatric medical advice is necessary prior to administration.
What if you forget to take Emstal 1mg/ml Suspension :
If your pediatrician hasn't directed otherwise, administer the forgotten dose upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate; instead, adhere to the recommended medication schedule.
Facts to Know About Emstal 1mg/ml Suspension
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Prokinetic agent with dopamine (D2) receptor antagonism |
